Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jun 2, 2025
Date Accepted: Nov 11, 2025
The effect of a digital health physical activity program integrating gamification for obesity management in comparison to the usual care: a randomized controlled trial with ideographic approach
ABSTRACT
Background:
Digital health interventions and gamification hold promise for managing chronic diseases, but evidence comparing their efficacy to usual care is limited.
Objective:
This two-arm parallel randomized controlled trial with embedded N-of-1 analyses assessed whether a digital intervention integrating gamification and telecoaching (Kiplin) outperforms a supervised face-to-face adapted physical activity (PA) program (usual care) in obesity management.
Methods:
Patients with obesity and/or T2D (N = 50, Mage = 46.7 years, 74% female) were randomized to either the Kiplin digital intervention or usual care group, and completed a 3-month program with a 6-month follow-up. The primary outcome was the change in daily step count between baseline and the intervention's end. Secondary outcomes assessed changes in daily steps, PA, quality of life, body composition, and physical capacities over nine months. Mixed-effects models and generative additive models were conducted to analyze both between- and within-person evolutions in PA. A cost-utility analysis was computed to compare the cost-effectiveness of the programs.
Results:
Compared to the usual care, Kiplin participants showed significant increases in daily steps during the intervention and follow-up periods, with sustained effect sizes. Idiographic analyses revealed variable individual responses. No significant differences were observed in secondary clinical outcomes or the cost-utility analysis.
Conclusions:
This study demonstrates the potential of digital interventions to sustain PA improvements, offering an alternative to face-to-face programs. However, individual heterogeneity in the response to the intervention highlights the need for tailored approaches, and the clinical and economic impacts need to be further evaluated. Clinical Trial: ClinicalTrials.gov, NCT04887077
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.